RESUMO
Electron microscopy was used in a semi-quantitative study to determine changes in the abundance and size of surface nexuses and changes in the abundance of interiorized nexuses in growing and mature ovarian follicles during the ovulatory process. Mature follicles contain larger granulosa cells than follicles in the early stage of antral formation. Also, the granulosa cells of mature follicles have a slightly greater number of surface nexuses (without a change in nexus length), and more interiorized nexuses, compared to immature follicles. As a mature follicle approaches rupture, there is an appreciable decrease in the number of surface nexuses per granulosa cell. There is also a slight reduction in the number of interiorized nexuses at this time. It is concluded that this decrease in both surface nexuses and interiorized nexuses may be a consequence of ovulatory changes during which the rate of granulosa cell division is greater than the rate of formation of new nexuses. Additionally, the disruption to cell-to-cell cohesion during the ovulatory process appears to be independent of the interiorization of surface nexuses.
Assuntos
Células da Granulosa/ultraestrutura , Junções Intercelulares/ultraestrutura , Folículo Ovariano/ultraestrutura , Ovulação , Animais , Feminino , CoelhosRESUMO
This study determined specifically when ovarian prostaglandins (PGs) increase during ovulation and how effectively different doses of indomethacin inhibit PGs and ovulation. Rabbit ovarian follicles were removed at hourly intervals after stimulating the animals with hCG (50 IU/kg). The follicles were homogenized in 0.1 M acetate buffer (pH 4.5), and the PGE and PGF in the extracts were measured by RIA. Ovulation rates were determined by calculating the percentage of mature follicles that ruptured after stimulation by hCG. Before hCG, the normal levels of PGE and PGF were 111.1 +/- 14.7 and 51.0 +/- 6.6 pg/mg follicle, respectively. By 2 h after hCG treatment, PGE and PGF both increased to 162.6 +/- 17.0 and 80.6 +/- 13.3 pg/mg follicle, respectively. Approximately 5 h later, there was a second, sharper increase in both PGs which peaked at 652.6 +/- 63.5 and 345.4 +/- 32.3 pg/mg follicle, respectively, 10 h after hCG treatment, i.e. at the expected time of ovulation. We found that regardless of whether indomethacin was given early or late during the ovulation process, this agent significantly reduced follicular PG production within 5 min after its administration. For example, only 5 min after 10 mg/kg indomethacin were administered 8 h after hCG, PGE and PGF dropped from 317.7 +/- 50.0 and 125.0 +/- 10.5 pg/mg follicle to 93.3 +/- 17.4 and 49.3 +/- 10.5 pg/mg follicle, respectively. Unexpectedly, when graded doses of indomethacin were administered either 1 or 8 h after hCG, there was not a statistically significant correlation between follicular PG levels and ovulation rate. For example, when doses of 1.25, 2.5, 5.0, and 10.0 mg/kg indomethacin were given 8 h after hCG, the PGE and PGF levels at the expected time of ovulation (i.e. 2 h later) were always equal to or less than the PG levels in follicles that had not been stimulated by hCG, yet ovulation proceeded at rates of 46.7 +/- 12.3%, 30 +/- 7.7%, 14.3 +/- 9.3%, and 0%, respectively. Therefore, the results raise questions about the specific role of PGs in the ovulation process.
Assuntos
Indometacina/farmacologia , Folículo Ovariano/metabolismo , Ovulação/efeitos dos fármacos , Prostaglandinas/metabolismo , Animais , Gonadotropina Coriônica/farmacologia , Relação Dose-Resposta a Droga , Feminino , Indometacina/administração & dosagem , Cinética , Folículo Ovariano/efeitos dos fármacos , Prostaglandinas E/metabolismo , Prostaglandinas F/metabolismo , Coelhos , Fatores de TempoRESUMO
The ovarian level of 15-hydroxyeicosatetraenoic acid (15-HETE) was measured by RIA during ovulation in gonadotropin-primed immature Wistar rats. The ovulatory process was initiated in 25-day-old rats by a 10-IU injection of hCG sc 2 days after the animals had been primed with 10 IU PMSG, sc. Ovarian follicles begin to ovulate 10 h after hCG. At 0 h after hCG, the ovarian 15-HETE level was 0.6 +/- 0.2 ng/mg ovarian protein. At 6 h the 15-HETE level increased sharply to 27.3 +/- 4.2 ng/mg protein and reached a peak of 50.0 +/- 9.8 ng/mg protein at 10 h. Ovarian 15-HETE decreased significantly between 10-16 h after hCG (when ovulation was essentially completed). The pattern of secretion of this 15-lipoxygenase product was reciprocal to the pattern of secretion of leukotriene-B4 by the rat ovary. Ovarian 15-HETE production and ovulation were inhibited in a dose-dependent manner when indomethacin was administered sc 1 h after hCG in doses ranging from 0.10-10.0 mg/rat. In contrast, the synthesis of ovarian prostaglandins-E and -F was inhibited by a dose of indomethacin as low as 0.0316 mg/rat, but this dose did not significantly affect the ovarian 15-HETE level or the ovulation rate. Therefore, the ovulation rate was more closely correlated with the ovarian 15-HETE level (P less than 0.001) than with the ovarian levels of either prostaglandin-E or -F (0.10 greater than P greater than 0.05). The results suggest that products of the 15-lipoxygenase pathway of arachidonic acid metabolism may be important in the biochemical events of mammalian ovulation.
Assuntos
Gonadotropina Coriônica/farmacologia , Ácidos Hidroxieicosatetraenoicos/biossíntese , Ovário/fisiologia , Ovulação , Animais , Feminino , Indometacina/farmacologia , Cinética , Leucotrieno B4/biossíntese , Ovário/efeitos dos fármacos , Ovulação/efeitos dos fármacos , Prostaglandinas E/biossíntese , Prostaglandinas F/biossíntese , Ratos , Ratos Endogâmicos , Maturidade SexualRESUMO
The antiovulatory action of epostane, an inhibitor of 3 beta-hydroxysteroid dehydrogenase activity and progesterone synthesis, was studied in the immature rat. The ovulatory process was induced in 25-day-old rats by injecting them with hCG (10 IU, sc) 2 days after the animals had been primed with PMSG (10 IU). Epostane was administered at different times between 20 h before and 11 h after hCG. Maximum inhibition of ovulation occurred when the drug was given at 3 h after hCG. Epostane inhibited ovulation in a dose-dependent manner when administered in doses ranging from 1.0-50 mg/rat, while exogenous doses of progesterone restored the ovulation rate. A dose of 3.1 mg epostane/rat 3 h after hCG reduced ovarian progesterone levels within 15 min, but the production of this steroid rebounded within 2 h and approached normal levels by 12 h after hCG, i.e. when the follicles began to rupture in control animals. 17 beta-Estradiol synthesis was inhibited just as rapidly, but it remained suppressed for up to 12 h after hCG administration. The ovarian levels of prostaglandins E2 and F2 alpha decreased approximately 30% within 2 h after the administration of epostane, but such a moderate reduction in the synthesis of ovarian prostanoids is usually not sufficient to block ovulation. The results show that epostane has a rapid, but transient, effect on ovarian progesterone synthesis. The temporary decline in the local progesterone level is apparently sufficient to interfere with the normal sequence of metabolic events that lead to the rupture of follicles.
Assuntos
Androstenóis/farmacologia , Dinoprosta/metabolismo , Dinoprostona/metabolismo , Estradiol/metabolismo , Ovário/metabolismo , Progesterona/metabolismo , 3-Hidroxiesteroide Desidrogenases/antagonistas & inibidores , Androstenóis/administração & dosagem , Animais , Gonadotropina Coriônica/farmacologia , Relação Dose-Resposta a Droga , Feminino , Ovário/efeitos dos fármacos , Ovulação/fisiologia , Progesterona/farmacologia , Ratos , Ratos EndogâmicosRESUMO
This investigation uses electron microscopy to examine the effect of prostaglandins on follicular tissue during the ovulatory process. The ultrastructure of follicles from indomethacin-treated rabbits was compared to the ultrastructure of normal ovulatory follicles in order to determine the morphological differences between follicles with negligible and normal prostaglandin synthesis, respectively. The most obvious difference between the two groups of follicles was that the tissue at the apex of normal follicles began to thin out significantly by 9 h post coitus (near the time of ovulation), whereas the follicles from indomethacin-treated animals showed no signs of thinning, even as late as 12 h post coitus. It appeared that the fibroblasts in the follicles with limited prostaglandin synthesis failed to undergo the normal ovulatory transformation from a quiescent to a proliferative state. Otherwise, the prostaglandin-deficient follicles had a number of morphological features similar to those which usually occur in ovulatory tissue. There was detectable loosening of the connective tissue elements and some indication of edema at the apex of the mature follicles. Also, granulocytes became localized in the vascular compartment of these follicles. In addition, there tended to be an increase in the multivesicular structures which protrude from the fibroblasts, as well as an increase in the dense granules which accumulate in the cytoplasm of the surface epithelial cells. Collectively, these data suggest that normal prostaglandin synthesis in ovulatory follicles may be important in the connective tissue decomposition and ultimate thinning of the follicle wall.
Assuntos
Indometacina/farmacologia , Folículo Ovariano/ultraestrutura , Ovulação/efeitos dos fármacos , Animais , Epitélio/ultraestrutura , Feminino , Folículo Ovariano/efeitos dos fármacos , CoelhosRESUMO
Involvement of the vasoactive peptide bradykinin (BK) in ovulation, oocyte maturation, and prostaglandin (PG) production was assessed using an in vitro perfused rabbit ovary preparation. In the first experiment, BK at a concentration of 0.033, 0.33, or 3.3 micrograms/ml was added to the perfusate of one ovary at hourly intervals for the first 10 h of perfusion. The contralateral control ovary was treated with medium alone parallel to the experimental ovary. Ovaries were perfused for a total of 12 h. BK induced ovulation in the absence of gonadotropin in a dose-related fashion, but did not induce maturation of ovulated ova or follicular oocytes. BK significantly stimulated PG production at all concentrations tested, but the effect was not dose related. Prostacyclin, as reflected by the concentration of 6-keto-PGF1 alpha in the perfusate, was the major PG produced. Smaller quantities of PGE2 and PGF2 alpha were present in the perfusate. After a single injection of BK (3.3 micrograms/ml), 6-keto-PGF1 alpha and PGF2 alpha production increased within 15 min and reached a maximum at 60-90 min. PGE2 did not change significantly over this time period. The addition of 1 microgram/ml indomethacin to the perfusate completely inhibited BK-stimulated PG production. However, indomethacin did not significantly affect the ovulatory efficiency of BK-treated ovaries. Neither BK nor indomethacin induced any degenerative changes in ovulated ova or follicular oocytes. The addition of a BK antagonist at 1 microgram/ml every 30 min to the perfusate resulted in an effective blockade of hCG-induced ovulation. These results suggest that BK is involved in the process of follicle rupture, but BK may induce ovulation by a mechanism(s) other than through PG stimulation.
Assuntos
Bradicinina/farmacologia , Ovário/metabolismo , Ovulação/efeitos dos fármacos , Prostaglandinas/biossíntese , 6-Cetoprostaglandina F1 alfa/biossíntese , Animais , Bradicinina/antagonistas & inibidores , Dinoprosta , Dinoprostona , Feminino , Indometacina/farmacologia , Cinética , Ovário/efeitos dos fármacos , Prostaglandinas E/biossíntese , Prostaglandinas F/biossíntese , CoelhosRESUMO
Current evidence supports the hypothesis that the biochemical events of mammalian ovulation are analogous to an acute inflammatory reaction. This study reveals that tumor necrosis factor-stimulated gene-6 (TSG-6), which encodes a member of the superfamily of hyaluronan-binding proteins that is specifically translated in inflammatory reactions, is expressed in ovarian follicles that have been induced to ovulate. Immature Wistar rats were primed with 10 IU equine CG s.c.; and 48 h later, the 12-h ovulatory process was initiated by 10 IU human CG (hCG), s.c.. Ovarian RNA was extracted at 0, 2, 4, 8, 12, and 24 h after the primed animals were injected with hCG. The RNA extracts were used for RT-PCR differential display of amplified complementary DNAs (cDNAs) that represented gene expression in the stimulated ovarian tissue. Northern analysis of one of the differentially amplified cDNAs confirmed that it was part of a gene that was substantially up-regulated at 4-8 h after the ovaries had been stimulated by hCG. Subcloning and sequence analysis revealed that the cDNA matched the gene for TSG-6. In situ hybridization indicated that the TSG-6 messenger RNA was primarily located in the cumulus mass and the antral granulosa cells of large ovarian follicles. In conclusion, the data show that expression of TSG-6 is an integral part of the cascade of inflammatory-like changes that occur in an ovulatory follicle in response to a trophic hormone that couples with luteinizing hormone/hCG receptors.
Assuntos
Moléculas de Adesão Celular/genética , Gonadotropina Coriônica/administração & dosagem , Expressão Gênica/efeitos dos fármacos , Ovário/metabolismo , Ovulação , Androstenóis/farmacologia , Animais , DNA Complementar/análise , DNA Complementar/química , Feminino , Hibridização In Situ , Indometacina/farmacologia , RNA Mensageiro/análise , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de DNARESUMO
Granulosa cells in a mature ovarian follicle have an abundance of LH/hCG receptors that respond rapidly to an ovulatory surge in gonadotropins. Within minutes, membrane signal transduction sets in motion metabolic changes that lead to follicular rupture. This study provides evidence that the initial ovarian response to such an ovulatory stimulus includes induction of the immediate-early transcription factor gene for early growth response protein-1 (Egr-1). Immature Wistar rats were primed with 10 IU equine CG (eCG), sc, and 48 h later the 12-h ovulatory process was initiated by 10 IU hCG, sc. Ovarian RNA was extracted at 0, 0.5, 1, 2, 4, 8, 12, and 24 h after the primed animals were injected with hCG. The RNA extracts were used for RT-PCR differential display for random detection of gene expression in the stimulated ovarian tissue. Northern analysis of one of the differentially amplified complementary DNAs confirmed that it was part of a gene that was significantly up-regulated within 1 h after the ovaries had been stimulated by hCG. Maximum transcription was at 4 h after hCG, and expression declined to 0 h control levels by 24 h after hCG. Subcloning and sequence analysis revealed that the complementary DNA matched the gene for Egr-1. In situ hybridization indicated that the Egr-1 messenger RNA was in the granulosa layer of mature follicles. Western blotting confirmed the temporal pattern of Egr-1 expression detected by differential display, Northern analysis and in situ hybridization. The Egr-1 protein is approximately 84 kDa. In conclusion, the data show that expression of the zinc finger transcription factor Egr-1 is an early event in the cascade of inflammatory-like changes that occur in an ovulatory follicle in response to a trophic hormone.
Assuntos
Gonadotropina Coriônica/farmacologia , Proteínas de Ligação a DNA/genética , Expressão Gênica/efeitos dos fármacos , Proteínas Imediatamente Precoces , Ovário/fisiologia , Fatores de Transcrição/genética , Androstenóis/farmacologia , Animais , DNA Complementar/genética , DNA Complementar/metabolismo , Proteína 1 de Resposta de Crescimento Precoce , Feminino , Humanos , Indometacina/farmacologia , Dados de Sequência Molecular , Ovulação/efeitos dos fármacos , Ovulação/fisiologia , Biossíntese de Proteínas , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Distribuição TecidualRESUMO
The ovulatory process in mammals involves gross physiological events in the ovary that cause transient deterioration of the ovarian connective tissue and rupture of the apical walls of mature follicles. This gonadotropin-induced process has features similar to an acute inflammatory reaction that affects most of the ovary. The present study reveals that the ovulatory events include induction of mRNA for pancreatitis-associated protein-III (PAP-III). Immature Wistar rats were primed with 10 IU equine chorionic gonadotropin s.c., and 48 h later the 12-h ovulatory process was initiated by 10 IU human chorionic gonadotropin (hCG) s.c. Ovarian RNA was extracted at 0, 2, 4, 8, 12 and 24 h after the animals were injected with hCG. The RNA extracts were used for RT-PCR differential display to detect PAP-III gene expression in the stimulated ovarian tissue. Northern blotting showed that transcription was significantly greater at 4-12 h after the ovaries had been stimulated by hCG. In situ hybridization indicated that PAP-III mRNA expression was limited mainly to the hilar region of the ovarian stroma, with most of the signal emanating from endothelial cells that lined the inner walls of blood vessels, and from small secondary follicles. Treatment of the animals with ovulation-blocking doses of indomethacin (an inhibitor of prostanoid synthesis) or epostane (an inhibitor of progesterone synthesis) revealed that ovarian transcription of PAP-III mRNA was moderately dependent on ovarian progesterone synthesis. In conclusion, the present evidence of an increase in PAP-III gene expression in gonadotropin-stimulated ovaries provides further evidence that the ovulatory process is comparable to an inflammatory reaction.
Assuntos
Antígenos de Neoplasias/genética , Biomarcadores Tumorais/genética , Gonadotropinas Equinas/farmacologia , Lectinas Tipo C/genética , Ovário/metabolismo , Ovulação/fisiologia , RNA Mensageiro/análise , Androstenóis/farmacologia , Animais , Northern Blotting , Feminino , Expressão Gênica , Indometacina/farmacologia , Proteínas Associadas a Pancreatite , Progesterona/antagonistas & inibidores , Antagonistas de Prostaglandina/farmacologia , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Estimulação Química , Fatores de TempoRESUMO
Plasminogen activator (PA) activity in the rat uterus was measured at fixed intervals post partum in order to determine whether this serine protease increases during the acute remodelling of tissue which occurs in the involuting uterus. Plasminogen activator activity was measured by an indirect method based on the hydrolysis of the chromogenic substrate S-2251 by PA-generated plasmin. At the time of parturition the control level of PA activity was 0.033 +/- 0.018 (S.D.) mumol/4 mg uterine wet weight per 30 min. This activity increased fourfold to a peak of 0.131 +/- 0.036 at 3 days post partum, and then it declined steadily towards the control level during the next 7 days. Concomitantly, uterine weight decreased to 25% of the control weight by 3 days post partum, and it continued to decrease until day 15. In the 30 days post partum during which PA activity was monitored there was no significant change in plasmin inhibitors in the uterine extracts. The results suggest a correlation between PA activity and the process of tissue remodelling which occurs during involution of the rat uterus. This increase in PA might serve to activate a latent collagenase since the measured peak in PA activity happens to coincide with a reported increase in collagenolytic activity in the involuting rat uterus.
Assuntos
Ativadores de Plasminogênio/metabolismo , Período Pós-Parto , Útero/metabolismo , Animais , Bioensaio , Feminino , Fibrinolisina/metabolismo , Humanos , Tamanho do Órgão , Gravidez , Ratos , Ratos Endogâmicos , Útero/anatomia & histologiaRESUMO
This study establishes the optimum time to administer colchicine to inhibit ovulation in the rabbit, and it examines the effect of colchicine on prostaglandin biosynthesis in ovulatory follicles. Colchicine (2 mg/kg) was given at intervals ranging from 50 hours to 2 hours before ovulation. The ovulation efficiency was significantly reduced when colchicine was administered between 30 hours and 9 hours before ovulation, with maximum inhibition occurring at 20 hours before ovulation. Normal elevation in prostaglandin biosynthesis at the time of ovulation was significantly reduced when colchicine was given at 20 hours before ovulation, but not when it was given at 9 hours or 2 hours before ovulation. The results suggest that the mechanism by which the antimitotic agent colchicine inhibits prostaglandin biosynthesis and ovulation may be different from that of the nonsteroidal antiinflammatory agent indomethacin.
Assuntos
Colchicina/farmacologia , Mitose/efeitos dos fármacos , Ovulação/efeitos dos fármacos , Animais , Feminino , Folículo Ovariano/metabolismo , Prostaglandinas E/biossíntese , Prostaglandinas F/biossíntese , CoelhosRESUMO
A wide variety of antiinflammatory agents and related compounds were administered to rabbits so that their ability to inhibit ovulation could be evaluated. In order of decreasing effectiveness, ovulation was inhibited by the nonsteroidal antiinflammatory agents diclofenac, indomethacin, fenoprofen, niflumate, tolmetin, phenylbutazone, naproxen, meclofenamate, ibuprofen, and flufenamate. Ovulation was not inhibited by aspirin, salicylate, or mefenamate, nor by the steroidal antiinflammatory agents dexamethasone (DEX) and prednisolone. The antineoplastic agents colchicine and vinblastine inhibited ovulation, but not azathioprine, 6-mercaptopurine, or cyclophosphamide. Contrary to previous reports, ovulation was not inhibited by the antihistamines chlorpheniramine, diphenhydramine, or cimetidine. Among the miscellaneous agents tested, ovulation was strongly inhibited by cycloheximide and slightly by acetaminophen but not by clomiphene, quinacrine, allopurinol, diethylstilbestrol (DES), heparin, melatonin, papaverine, chloroquine, D-penicillamine, or levamisole. These results show that ovulation can be inhibited by agents that inhibit acute inflammatory reactions.
Assuntos
Anti-Inflamatórios/farmacologia , Ovulação/efeitos dos fármacos , Animais , Antineoplásicos/farmacologia , Cicloeximida/farmacologia , Feminino , Antagonistas dos Receptores Histamínicos H1/farmacologia , CoelhosRESUMO
The luteinizing hormone (LH) surge initiates a cascade of proteolytic events that control ovulation. One of the genes induced by LH is the progesterone receptor (PR). Because mice with a mutant PR gene (PRKO) fail to ovulate and are infertile, we have used them as a model in which to determine PR target genes that might mediate the ovulatory process. The matrix metalloproteinases (MMPs: MMP2, MMP9, and MMP13) appear to be expressed in ovaries of PRKO mice in a manner similar to that in their wild-type littermates. However, the expression of two other types of proteases, cathepsin L (a member of the papain family) and ADAMTS-1 (A Disintegrin And Metalloproteinase with Thrombospondin-like motifs), are selectively induced in granulosa cells of preovulatory follicles by the LH surge. Maximal levels of these proteases are observed at 12-16 h after an LH surge, the time of ovulation. Furthermore, mRNAs encoding cathepsin L and ADAMTS-1 are reduced in the PRKO mice compared to their wild-type littermates. These novel observations indicate that these two proteases regulate some key step(s) controlling ovulation.
Assuntos
Endopeptidases , Ovulação/genética , Ovulação/fisiologia , Proteínas ADAM , Proteína ADAMTS1 , Animais , Proteínas Estimuladoras de Ligação a CCAAT/genética , Catepsina L , Catepsinas/genética , Catepsinas/farmacologia , Ciclo-Oxigenase 2 , Cisteína Endopeptidases , Desintegrinas/genética , Desintegrinas/farmacologia , Feminino , Regulação da Expressão Gênica , Células da Granulosa/metabolismo , Isoenzimas/genética , Isoenzimas/farmacologia , Hormônio Luteinizante/efeitos dos fármacos , Hormônio Luteinizante/farmacologia , Metaloproteinases da Matriz/efeitos dos fármacos , Metaloproteinases da Matriz/farmacologia , Metaloendopeptidases/genética , Metaloendopeptidases/farmacologia , Camundongos , Camundongos Knockout , Folículo Ovariano/citologia , Folículo Ovariano/metabolismo , Regiões Promotoras Genéticas , Prostaglandina-Endoperóxido Sintases/genética , Prostaglandina-Endoperóxido Sintases/farmacologia , RNA Mensageiro/metabolismo , Ratos , Receptores de Progesterona/genética , Receptores de Progesterona/metabolismo , TransfecçãoRESUMO
The most important activity during the follicular phase of the cycle is the secretion of gonadotropins, which control folliculogenesis and influence uterine proliferation. The dominant events of the periovulatory phase are the LH surge and ovulation. The significant change during the luteal phase is the production of a nutritive mucus by the endometrial glands in preparation for an embryonic blastocyst. The cardinal passage of the menstrual phase is the menstrual flow itself. These different events (and the metabolic processes that regulate them) have wide-ranging effects on the integrity of the body. As Havelock Ellis, the eminent English psychologist, stated at the turn of this century, "the omnipresent process of sex, as it is woven into the whole texture of our body, is the pattern of all the process of our life" (source unknown). The sweeping influences of the menstrual cycle illustrate the extent to which the process of reproduction is indeed woven into the whole of the human body.
Assuntos
Ciclo Menstrual/fisiologia , Feminino , Humanos , Sistema Hipotálamo-Hipofisário/fisiologiaRESUMO
Cycloheximide (5 mg/kg, i.v.) significantly inhibited ovulation in the rabbit when it was administered as early as 20 h before the ovulation process was initiated by hCG, and as late as 1 h after hCG. The ovulation rate was significantly reduced, but follicular biosynthesis of prostaglandins E and F was only partly inhibited. The biosynthesis of progesterone and oestradiol in follicles during the early stages of the ovulation process was also inhibited. Cycloheximide may therefore inhibit ovulation by a mechanism which is different from the action of indomethacin, and this mechanism may involve the suppression of ovarian steroidogenesis.
Assuntos
Cicloeximida/farmacologia , Hormônios Esteroides Gonadais/biossíntese , Folículo Ovariano/metabolismo , Ovulação/efeitos dos fármacos , Prostaglandinas/biossíntese , Animais , Depressão Química , Estradiol/biossíntese , Feminino , Progesterona/biossíntese , Prostaglandinas E/biossíntese , Prostaglandinas F/biossíntese , Coelhos , Fatores de TempoRESUMO
This presentation reviews current information on the events that lead to rupture of an ovarian follicle. It contains a summary of the morphological changes that occur at the apex of a follicle wall during ovulation. Existing information shows that the tenacious connective tissue layers of the tunica albuginea and theca externa must be weakened before the follicle wall can dissociate and break open under the force of a modest intrafollicular pressure. These changes are probably dependent on transformation of quiescent thecal fibroblasts into proliferating cells in a manner that is characteristic of tissue responses to inflammatory reactions. The metabolic factors that initiate transformation of the fibroblasts are uncertain, but they are probably generated by gonadotropin-induced changes in the theca interna and granulosa of a follicle as these layers begin to luteinize during the ovulatory process.